Edition:
India

Michael Erman

Bristol-Myers says shareholders vote to approve Celgene takeover

12 Apr 2019

NEW YORK Bristol-Myers Squibb Co's shareholders voted to approve the drugmaker's $74 billion acquisition of biotech Celgene Corp on Friday despite a campaign by activist hedge fund Starboard Value LP to scuttle the deal.

Sanofi to cut U.S. insulin costs for some patients to $99 per month

10 Apr 2019

NEW YORK Sanofi SA said on Wednesday it will cut the cost of its insulin products to $99 per month for uninsured patients and others who pay cash for it in the United States, as the French drugmaker contends with intense criticism over the high price of the life-sustaining diabetes medication.

Starboard abandons campaign to scuttle Bristol-Myers-Celgene deal

29 Mar 2019

NEW YORK Activist hedge fund Starboard Value LP on Friday abandoned a campaign to convince Bristol-Myers Squibb Co shareholders to vote down the drugmaker's proposed $74 billion takeover of biotech Celgene Corp after the two leading proxy advisory firms backed the deal.

U.S. health insurer Centene to buy smaller rival WellCare for $15.3 billion

28 Mar 2019

U.S. health insurer Centene Corp on Wednesday said it would buy smaller rival WellCare Health Plans Inc for $15.27 billion, in a move to bulk up its government-backed Medicare and Medicaid businesses while reducing exposure to Obamacare healthcare exchanges. | Video

UPS eyes in-home health services with U.S. vaccine project

22 Mar 2019

LOUISVILLE, Ky. - United Parcel Service Inc wants to get beyond U.S. doorsteps with a new push into healthcare. | Video

UPS eyes in-home health services with U.S. vaccine project

22 Mar 2019

LOUISVILLE, Ky. - United Parcel Service Inc wants to get beyond U.S. doorsteps with a new push into healthcare.

Starboard joins opposition to Bristol-Myers' $74 billion Celgene deal

01 Mar 2019

Activist hedge fund Starboard Value LP followed Bristol-Myers Squibb Co's second-largest investor, Wellington Management, in opposing the drugmaker's $74 billion purchase of biotech Celgene Corp on Thursday, sowing further doubt on what would be the largest pharmaceutical takeover ever.

World News